胰腺分泌的主要蛋白酶是胰蛋白酶原和胰凝乳蛋白酶原。
The major proteases which the pancreas secretes are trypsinogen and chymotrypsinogen.
主细胞制造和分泌胃蛋白酶原。
酶原颗粒减少，线粒体肿胀。
The zymogen granules decreased and the mitochondria was swollen.
肠致活酶作用于蛋白酶原。
目的：探讨凝血酶原时间测定的部分影响因素。
Objective: to investigate the part influence factors of prothrombin time assay.
酚氧化酶原和溶酶菌均是对虾重要的免疫因子。
Both prophenoloxidase and Lysozyme are important immune factors in shrimps.
有些细胞外酶原能被分泌的溶酶体蛋白酶所激活。
Some extracellular proenzymes may be activated by secreted lysosomal proteinases.
目的：研究凝血酶原活性与肝硬化病人预后的关系。
Objective: To study the relationship between prothrombin coagulative activity and the prognosis of patients with liver cirrhosis.
尿激酶是一种纤溶酶原激活剂，临床上用于治疗血栓。
Urokinase, a human plasminogen activator, is used clinically to promote the dissolution of thrombi.
结果在正常大鼠肝组织中有MMP -3的酶原表达。
Results MMP-3 proenzyme protein could be detected in normal rat liver.
作者研究了血浆和组织激肽释放酶激活纤溶酶原的机制。
We studied the mechanism of plasma and tissue kallikrein in activating plasminogen.
目的探讨米非司酮对血小板、血浆凝血酶原时间的影响。
Objective to explore effects of blood platelets and prothrombin time on mifepristone.
当组织损伤时，释放出凝血致活酶，把凝血酶原变成凝血酶。
When the tissue damage, the release of thromboplastin to prothrombin into thrombin.
结果所有受检者均未发现凝血酶原G20210A基因突变。
Results No prothrombin gene G20210A mutation was found in both patients and controls.
此外，血清胆红素水平开始下降，部分凝血酶原时间恢复正常。
In addition, the serum bilirubin level began to decrease and the partial-thromboplastin time returned to normal.
研究者也发现骨桥蛋白基因的表达触发了纤维蛋白酶原基因的表达。
The researchers also found that osteopontin gene expression triggered the expression of profibrogenic genes.
凝血酶原基因g20210a突变，可导致血浆凝血酶原水平升高。
Prothrombin G20210A mutation can lead to plasma prothrombin level increase.
目的：探讨尿胰蛋白酶原鄄2测定在急腹症中筛选急性胰腺炎的价值。
Objective: To evaluate the values of urinary trypsinogen, 2 test in screening for acute pancreatitis in patients with acute abdomen.
结论凝血酶原突变基因20210A可能增加了胃癌的遗传易感性。
Conclusion Prothrombin 20210a gene mutation may increase genetic susceptibility of gastric cancer.
然而，观察期间在总胆红素和凝血酶原时间方面两组之间没有显著差异。
However, there was no significant difference in the total bilirubin and prothrombin time in either group during the observation periods.
大多数肝硬化腹水的患者凝血酶原时间延长并有一定程度的血小板减少。
The majority of patients with ascites due to cirrhosis have prolongation of the prothrombin time and some degree of thrombocytopenia.
目的观察应用重组组织型纤溶酶原激活剂溶栓治疗急性心肌梗死的效果。
Objective to observe the effect of recombinant tissue plasminogen activator in the treatment of acute myocardial infarction.
目的探讨试纸法尿胰蛋白酶原-2快速测定在急腹症中筛选急性胰腺炎的意义。
Objective To explore the significance of urinary trypsinogen-2 test for screening acute pancreatitis in patients with acute abdomen.
本文就酚氧化酶及其酶原的生化特性和分子生物学特性研究的进展情况予以综述。
In this paper, the research process of biochemical characteristics and molecular biology of the PO were reviewed.
目的探讨急性冠状动脉综合征患者内皮组织纤溶酶原激活剂储备功能的变化规律。
Objective To study the changes of the endothelial tissue plasminogen activator reserve capacity in patients with acute coronary syndromes.
纤溶酶原和尿激酶前体的相互活化作用在纤溶的开始和加速上发挥着重要的作用。
Reciprocal activation of prourokinase and plasminogen is an important mechanism in the initiation and propagation of local fibrinolytic activity.
治疗组血小板计数、凝血酶原时间及血浆黏度变化与对照组相似（P>0.05）。
There was no significant difference in platelet count, plasma prothrombin time and plasma viscosity between treatment group and control group ( P > 0.05) .
凝血酶原时间和国际标准化比值应仔细监测患者同时管理ISTODAX和香豆衍生物。
Prothrombin time and International Normalized Ratio should be carefully monitored in patients concurrently administered ISTODAX and Coumadin derivatives.
凝血酶原时间和国际标准化比值应仔细监测患者同时管理ISTODAX和香豆衍生物。
Prothrombin time and International Normalized Ratio should be carefully monitored in patients concurrently administered ISTODAX and Coumadin derivatives.
应用推荐